Maryland Heights, MO, January 18, 2017 --(PR.com
)-- The global bone densitometers market to reach nearly USD 1.25 Billion in 2020, at a CAGR of 7.7% from 2016 to 2020. North America accounted for the largest global market for bone densitometers. Higher incidence of osteoporosis, bone related diseases, increasing Baby Boomer population are the major drivers for the growth of the market in this region. Huge demand for crucial diagnosis and corresponding therapies also has contributed to the growth of the market. In Europe, the market in countries such as U.K., Spain, Belgium, Italy, Germany and Austria are mainly driven by significant rise in incidences of hip fracture, increase in awareness about disease diagnosis, where either partial or full reimbursement for bone density measurement is provided.
Bone density or bone mineral density (BMD) is the amount of bone mineral in bone tissue. Bone density measurement is used in clinical medicine as an indirect indicator of osteoporosis and fracture risk. Bone densitometers are known to offer improved diagnostic sensitivity in cases of osteoporotic fractures, playing a vital role in diagnosis of facture before it could occur. It is measured by a procedure called densitometry, often performed in the radiology or nuclear medicine departments of hospitals or clinics. The measurement is painless and non-invasive and involves low radiation exposure. There has been an increasing interest in orthopedic medical communities towards bone mineral content and density measurement in the axial and peripheral skeletal regions of the human body due to higher incidences of osteoporosis, rising aging population prone to loss of bone mass, globally.
Browse Bone Densitometers Market – Technology (Axial Bone Densitometry, Dual Energy X-Ray Absorptiometry, Quantitative Computed Tomography, Peripheral Bone Densitometry, Single Energy X-Ray Absorptiometry, Dual Energy X-Ray Absorptiometry, Radiographic Absorptiometry, Quantitative Ultrasound, Peripheral Quantitative Computed Tomography), and End Users (Hospital-Based Bone Densitometers, Clinic-Based Bone Densitometers) 2016-2020 report at https://www.ihealthcareanalyst.com/report/bone-densitometers-market/
The global bone densitometers market segmentation is based on technology (axial bone densitometry, dual energy x-ray absorptiometry, quantitative computed tomography, peripheral bone densitometry, single energy x-ray absorptiometry, dual energy x-ray absorptiometry, radiographic absorptiometry, quantitative ultrasound, peripheral quantitative computed tomography), and end users (hospital-based bone densitometers, clinic-based bone densitometers). The Europe bone densitometers market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020).
The global bone densitometers market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global bone densitometers market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global bone densitometers market and included in this report are Hologic, Inc., GE Healthcare Ltd., CompuMed, Inc., BeamMed, Ltd., Osteometer MediTech, Inc., Lone Oak Technologies LLC and Diagnostic Medical Systems, S.A.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043